WCM
TNDM icon

Westend Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Westend Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-27
Closed -$956 – 318
2024
Q1 		$956 Buy
+27
New +$723 ﹤0.01% 275

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Westend Capital Management's TNDM Position: Q2 2024 in Review

Westend Capital Management sold out of Tandem Diabetes Care (TNDM) in Q2 2024, closing a stake of 27 shares — an estimated $956 sold.

Westend Capital Management first reported a position in TNDM in Q1 2024 and held it in 1 quarter. The position peaked at $956 in Q1 2024. 317 funds tracked by Wall St. Rank hold TNDM as of Q2 2024.

  • Westend Capital Management reported no remaining Tandem Diabetes Care position as of Q2 2024 after selling out during the quarter.
  • Westend Capital Management sold 27 Tandem Diabetes Care shares in Q2 2024, an estimated $956.
  • Westend Capital Management first reported a position in Tandem Diabetes Care in Q1 2024 and held it in 1 quarter.
  • Westend Capital Management's Tandem Diabetes Care position peaked at $956 in Q1 2024.
  • 317 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2024.

Based on Westend Capital Management's 13F filing for Q2 2024, filed 8 Jul 2024.